Alternative therapies in health and medicine, cilt.30, sa.7, ss.58-64, 2024 (SCI-Expanded)
Objectives: This study was conducted to evaluate the effect of telehealth education and art therapy on diet-fluid restriction and anxiety in hemodialysis patients during the COVID-19 pandemic. Methods: This randomized controlled study included 60 hemodialysis patients (30 in the intervention group and 30 in the control group). Data were collected using the Patient Information Form, Dialysis Diet and Fluid Non-Adherence Questionnaire, Beck Anxiety Inventory, and Modified Morisky Scale. Patients were educated about diet and fluid restriction according to their needs. The forms were applied to the patients at the first interview 6th week, and 12th week. Additionally, training on diet and fluid restriction was given at the first meeting, and an educational booklet was distributed to the patients. Thereafter, the patients were video-called one day a week for 12 weeks and the follow-up evaluation form was applied via telephone. The academician, who works at the University's Faculty of Education, Department of Fine Arts, assisted patients in drawing via video conference. Patients' drawing time is 60 minutes in total, two days a week, 30 minutes each time. Results: Following the education and drawing activity, systolic blood pressure, diastolic blood pressure, hemodialysis admission weight, creatinine values, frequency and degree of dietary non-compliance, frequency of non-compliance with fluid restriction, and anxiety levels of patients in the intervention group receiving hemodialysis treatment decreased (P < .05) and their compliance with treatment increased. Conclusion: Telehealth applications and art therapy are effective in improving compliance with diet and fluid restriction and controlling anxiety among hemodialysis patients. Since the use of telehealth methods to meet the educational needs of patients and integrative methods such as art therapy ensures the continuity of care services for patients during epidemic periods, it is recommended to be used in COVID-19 and other possible epidemics in the future.